Vicarious Surgical

RBOT · OTC

$0.0004−$0.0196 (−98.00%)TodayMarket closed · Oct 20, 4:41 PM ET

Prev close $0.02

RBOT analyst rating

HoldConsensus of 1 analyst over the last 12 months. 0% rate it a buy.

Strong buy0
Buy0
Hold1
Underperform0
Sell0

12-month price target · 3 analysts

Average $5.10 (+1274900.0% upside)

Low: $5.05
Now: $0.0004
High: $5.25

The case for and against

Updated Nov 28, 2024

Bull case

Vicarious Surgical Inc has demonstrated effective expense management, with a total operating expense of $17.7 million in Q2 reflecting a 17% decrease year-over-year, which is indicative of the company's commitment to financial discipline. The company's research and development expenditures of $8.5 million were significantly lower than projected, suggesting more efficient use of resources in advancing technology. Moreover, the reaffirmation of the timeline for the Vicarious Surgical Robotic System's version 1.0 integration by fall 2024 underscores management's confidence in their technological advancements and projected commercialization goals.

Bear case

Vicarious Surgical Inc reported significant adjusted net losses in both the latest quarter and prior quarter, underscoring its struggles with profitability as the adjusted EPS of -$2.86 fell short of the Street's expectation of -$2.72. Elevated investment risk associated with the ongoing development of its surgical robot, coupled with concerns around potential future share dilution from equity financings, adds to the company’s financial challenges. The reduction in the company’s cash balance and increased share count also contributed to a lowered price target, reflecting a cautious outlook on long-term viability.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.